1. For example, they can produce anthrax and botulinum toxin.

2. Botulinum toxin was injected into the masseter muscle and temporal muscle in the experimental group.

3. Some of them needed botulinum toxin injections in the pretarsal part of orbicularis oculi muscles.

4. Objective To observe the clinical effects of Botulinum toxin A(BTX-A) injection on children with spastic diplegia.

5. AIM: To explore the effects of botulinum toxin A in improving the abduction activity of carpometacarpal joint of thumb and spasm in spastic cerebral palsy patients with adduction deformity thumb.

6. Objective:To investigate the effect and mechanisms of botulinum toxin type A(BTA)on vasomotor rhinitis.

7. ObjectiveTo evaluate the effects of Botulinum toxin type A(BTX-A) repeated injection into detrusor to treat detrusor hyperreflexia and neurogenic incontinence in spinal cord injury(SCI) patients.

8. Botox, the commercial name of botulinum toxin type A, is a neuro-toxin produced by Clostridium botulinum. It can block the signals that make your muscles move.

9. Injectable fillers and botulinum toxin are suitable for people with busy lifestyles who do not want the inconvenience of a long recovery.

10. Objective To investigate the curative effects of botulinum toxin type A on hemifacial spasm.

11. Objective : To investigate the efficacy botulinum toxin A in the treatment of hemifacial spasm and blepharospasm.

12. Since then, several studies have evaluated botulinum toxin as a migraine preventative.

13. Conclusions Botulinum toxin type A local injection is a safe, effective, simple and easy means for the treatment of facial muscle dystonia.

14. Intraprostatic Botulinum Toxin Type A injection in patients with benign prostatic enlargement: duration of the effect of a single treatment.

15. Objective To investigate the use of botulinum toxin (BTX) A in the treatment of palatal myoclonus objective tinnitus (PMOT).

16. Objective To study the effects of botulinum toxin A(BTX -A)intramuscular injection and comprehensive rehabilitation on correcting the cerebral function deformity in cerebral palsy(CP).

16. Wish you can benefit from our online sentence dictionary and make progress every day!

17. Botox is the trade name for botulinum toxin – a protein produced by the Clostridium botulinum bacterium.

18. ObjectiveTo investigate the effect of injecting botulinum toxin A ( BTA ) in patients with congenital nystagmus ( CN ).

19. Botox, the commercial name of botulinum toxin type A, is a neuro-toxin produced by Clostridium botulinum.

20. ObjectiveTo investigate the effect of injecting botulinum toxin A ( BTA ) in patients congenital nystagmus ( CN ).

21. Every 13 weeks Beck receives 300 units of the botulinum toxin, which reaches peak effect in about five weeks.

22. Objective : To compare effectrelaxation of spasticity in cerebral palsy by Botulinum Toxin A and phenol block.

23. Objective To observe the clinical effect of blepharospasm and facial spasm with botulinum toxin A.

24. Objective : To study the long term therapeutic effects of botulinum toxin type A on hemifacial spasm.

25. Objective To observe the clinical efficacy and safety of pericranial intramuscular administration (PIA) of botulinum toxin A (BTXA) in patients with tension type headache (TTH).

26. Objective To explore the effects of using different doses of Botulinum Toxin Type A(BTX-A)in the treatment of masseteric hypertrophy.

27. The two most toxic chemicals for humans, that we know of, are botulinum toxin and tetanospasmin.

28. Follow-up evaluations were at 4 and 12 weeks after injection, when the study was unblended , with further follow-up in the botulinum toxin type A group at 24 weeks.

29. Botox is the marketing name given to a neurotoxin called botulinum toxin A.

30. We describe two cases of granular parakeratosis. In case one, the lesions cleared rapidly and completely after botulinum toxin injections to the axillae and groins.